New York-based health tech company Handspring Health has acquired Seattle startup Joon Care, marking a strategic move to strengthen its digital mental healthcare services for young people and families. The financial terms of the deal were not disclosed.
Handspring CEO Sahil Choudhry called the acquisition a pivotal step toward developing “the most clinically rigorous and digitally engaging platform for youth and family mental healthcare in the country,” in a post on LinkedIn.
Founded in 2019, Joon Care has focused on providing online therapy for individuals aged 13 to 26. Its programs combine digital tools with virtual counseling sessions, addressing issues such as anxiety, depression, disordered eating, gender and sexual identity challenges, and academic stress. Typical treatment courses run about 16 weeks, with outcomes closely tracked through evidence-based assessments.
The startup emerged from Seattle’s Pioneer Square Labs and secured $3.5 million in initial funding in 2020. A subsequent $6 million round in 2022 was intended to sustain operations for two to three years, according to former CEO Emily Pesce.
Handspring plans to merge the teams from both companies, though it has not confirmed whether all 50 of Joon Care’s employees will remain. Handspring, launched in 2021, has raised $18.2 million and provides virtual mental health services to a slightly broader age group of 8 to 29.
Both companies operate across multiple states. Joon Care holds licenses in Washington, Oregon, California, Texas, New York, Delaware, and Pennsylvania, and its programs are covered by 16 insurance providers, including major names such as Aetna and UnitedHealthcare.
In addition to insurance-covered care, Joon Care has partnered with the City of Seattle since 2023, offering free services to clients referred through municipal human services programs. Handspring
Related Topics:
ImpetusDX Dental Clinic Launches Rapid Oral Microbial Test as Gum Disease Rates Rise
New Oral SERD Therapy Shows Promise in Reducing Breast Cancer Recurrence
New Oral Diabetes Drug Burns Fat, Preserves Muscle, and Controls Blood Sugar, Study Shows
